Shijing Jia

723 total citations
20 papers, 224 citations indexed

About

Shijing Jia is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Emergency Medical Services. According to data from OpenAlex, Shijing Jia has authored 20 papers receiving a total of 224 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 3 papers in Physiology and 3 papers in Emergency Medical Services. Recurrent topics in Shijing Jia's work include Cystic Fibrosis Research Advances (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Neonatal Respiratory Health Research (3 papers). Shijing Jia is often cited by papers focused on Cystic Fibrosis Research Advances (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Neonatal Respiratory Health Research (3 papers). Shijing Jia collaborates with scholars based in United States, Australia and China. Shijing Jia's co-authors include Jennifer L. Taylor‐Cousar, Kevin K. Kim, Manisha Agarwal, Eric S. White, Jeffrey C. Horowitz, Jibing Yang, Mitchell Goheen, Song Ling, Daniel J. Tschumperlin and John J. Osterholzer and has published in prestigious journals such as CHEST Journal, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Shijing Jia

16 papers receiving 224 citations

Peers

Shijing Jia

PRM

IMMUN

PMH

Tanja Todberg Denmark

Saliha Esenboğa Türkiye

Priyanka Debta India

F. Poli Italy

Paul Cockrum United States

Marcela Valverde‐Monge Spain

Aparna Padiyar United States

Tali Stauber Israel

Michael A. Portelli United Kingdom

Clarice X. Lim Austria

Tanja Todberg Denmark

Shijing Jia

37 ×0.3

PRM

29 ×0.8

15 ×0.6

91 ×3.6

IMMUN

8 ×0.3

PMH

Citations per year, relative to Shijing Jia Shijing Jia (= 1×) peers Tanja Todberg

Countries citing papers authored by Shijing Jia

Since Specialization

Citations

This map shows the geographic impact of Shijing Jia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shijing Jia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shijing Jia more than expected).

Fields of papers citing papers by Shijing Jia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shijing Jia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shijing Jia. The network helps show where Shijing Jia may publish in the future.

Co-authorship network of co-authors of Shijing Jia

This figure shows the co-authorship network connecting the top 25 collaborators of Shijing Jia. A scholar is included among the top collaborators of Shijing Jia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shijing Jia. Shijing Jia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Xiaoxiang, et al.. (2025). Exercise training improves metabolic and circulatory function in COPD patients with NAFLD: evidence from clinical and molecular profiling. Frontiers in Medicine. 12. 1660072–1660072.

Sciurba, Frank C., Shijing Jia, & Shyam Subramanian. (2025). Ensifentrine: a novel approach to redefining COPD management and implications for additional respiratory diseases. Expert Opinion on Pharmacotherapy. 26(7). 809–820.

Jia, Shijing, Jonathan B. Zuckerman, Susan Murray, et al.. (2024). Association between CFTR modulators and changes in iron deficiency markers in cystic fibrosis. Journal of Cystic Fibrosis. 23(5). 878–884. 3 indexed citations

Leonard, Amanda, Julianna Bailey, Amanda S. Bruce, et al.. (2023). Nutritional considerations for a new era: A CF foundation position paper. Journal of Cystic Fibrosis. 22(5). 788–795. 31 indexed citations

Gifford, Alex H., Shijing Jia, Samya Z. Nasr, et al.. (2023). Complications and Practice Variation in the Use of Peripherally Inserted Central Venous Catheters in People With Cystic Fibrosis. CHEST Journal. 164(3). 614–624. 3 indexed citations

Fung, Christopher, Shijing Jia, Jonathan P. Troost, et al.. (2022). Asthma and coronavirus disease 2019–related outcomes in hospitalized patients. Annals of Allergy Asthma & Immunology. 129(1). 79–87.e6. 6 indexed citations

Hartzler, Andrea L., Siddhartha G. Kapnadak, Donna L. Berry, et al.. (2022). Take on transplant: human-centered design of a patient education tool to facilitate informed discussions about lung transplant among people with cystic fibrosis. Journal of the American Medical Informatics Association. 30(1). 26–37. 4 indexed citations

Jia, Shijing & Jennifer L. Taylor‐Cousar. (2022). Cystic Fibrosis Modulator Therapies. Annual Review of Medicine. 74(1). 413–426. 45 indexed citations

Crass, Ryan L., et al.. (2022). Acute kidney injury in cystic fibrosis patients treated with intravenous colistimethate sodium or tobramycin. Journal of Antimicrobial Chemotherapy. 77(9). 2516–2521.

10.

Zuckerman, Jonathan B., Joel Mermis, Patrick A. Flume, et al.. (2022). 28 A multi-center study of peripherally inserted central venous catheters: Predictors of difficult line insertion, malfunction, and soft tissue injury. Journal of Cystic Fibrosis. 21. S17–S18. 1 indexed citations

11.

Garcia, Michael A., Garrett Rampon, Gheorghe Doros, et al.. (2021). Rationale and Design of the Awake Prone Position for Early Hypoxemia in COVID-19 Study Protocol: A Clinical Trial. Annals of the American Thoracic Society. 18(9). 1560–1566. 2 indexed citations

12.

FitzGerald, Liesel M., et al.. (2021). 463: Clearance of colonized bacterial species in CF patients before and after elexacaftor/tezacaftor/ivacaftor. Journal of Cystic Fibrosis. 20. S219–S219. 3 indexed citations

13.

Crass, Ryan L., et al.. (2021). Pharmacokinetics of Polymyxin B in Hospitalized Adults with Cystic Fibrosis. Antimicrobial Agents and Chemotherapy. 65(10). e0079221–e0079221. 9 indexed citations

14.

Crass, Ryan L., et al.. (2021). 243: Polymyxin B pharmacokinetics in adult CF patients. Journal of Cystic Fibrosis. 20. S118–S118.

15.

Agarwal, Manisha, Mitchell Goheen, Shijing Jia, et al.. (2020). Type I Collagen Signaling Regulates Opposing Fibrotic Pathways through α2β1 Integrin. American Journal of Respiratory Cell and Molecular Biology. 63(5). 613–622. 18 indexed citations

16.

Combs, M.P., David Wheeler, Elizabeth A. Belloli, et al.. (2020). Prevalence and Prognosis of Updated Phenotypes of Chronic Lung Allograft Dysfunction. The Journal of Heart and Lung Transplantation. 39(4). S162–S163. 1 indexed citations

17.

Horowitz, Jeffrey C., Daniel J. Tschumperlin, Kevin K. Kim, et al.. (2019). Urokinase Plasminogen Activator Overexpression Reverses Established Lung Fibrosis. Thrombosis and Haemostasis. 119(12). 1968–1980. 21 indexed citations

18.

Jia, Shijing, Manisha Agarwal, Jibing Yang, et al.. (2018). Discoidin Domain Receptor 2 Signaling Regulates Fibroblast Apoptosis through PDK1/Akt. American Journal of Respiratory Cell and Molecular Biology. 59(3). 295–305. 37 indexed citations

19.

Agarwal, Manisha, et al.. (2017). Lung epithelial cell focal adhesion kinase signaling inhibits lung injury and fibrosis. American Journal of Physiology-Lung Cellular and Molecular Physiology. 312(5). L722–L730. 36 indexed citations

20.

Jia, Shijing, Douglas Brown, Anji Wall, Ira J. Kodner, & Jason D. Keune. (2013). Industry-sponsored clinical trials: the problem of conflicts of interest.. PubMed. 98(5). 32–5. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact